Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Marker Therapeutics ( (MRKR) ) has provided an announcement.
On February 12, 2024, Marker Therapeutics’ Board of Directors approved a discretionary award of 30,000 stock options to each of three non-employee directors. These stock options vest annually over three years, aligning with the company’s strategic compensation plan to incentivize leadership and potentially enhance company performance.
More about Marker Therapeutics
YTD Price Performance: -50.63%
Average Trading Volume: 81,635
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $16.81M
For an in-depth examination of MRKR stock, go to TipRanks’ Stock Analysis page.
